Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this program is to evaluate an effort to provide a comprehensive package of
HIV prevention services of which post-exposure prophylaxis (medicines that may help prevent
HIV infection after an exposure) can be a part. It will also include risk reduction
information and testing for other sexually transmitted infections.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
AIDS Project Los Angeles Los Angeles County Department of Public Health Los Angeles LGBT Center OASIS Clinic The OASIS Clinic
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Lamivudine, zidovudine drug combination Lopinavir Ritonavir Tenofovir